BLLN Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into BillionToOne (BLLN)
NEW YORK CITY, NY / ACCESS Newswire / November 20, 2026 /Shareholders of BillionToOne, Inc. (NASDAQ:BLLN) saw roughly investment 's value falter on November 18, 2026, after Fuzzy Panda Research published a short-seller report alleging improper billing and reimbursement practices at the Company. If you held BLLN and lost money, you may have legal rights. Investors who suffered losses are encouraged to submit your BLLN loss details now or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.
In its Form 10-Q filed November 4, 2026, BillionToOne reported that $19.6 million of its revenue for the nine months ended September 30, 2026 related to performance obligations satisfied in prior periods, including reprocessed claims from 2025.
On the November 4, 2026 earnings call, Chief Financial Officer Ross Taylor reported $7.6 million in third-quarter true-up revenue from prior-period claims, compared with $2.8 million in the second quarter and $3.7 million a year earlier. That figure was $1.1 million in the fourth quarter of 2024 and $9.2 million in the first quarter of 2026. Levi & Korsinsky is investigating potential securities law violations on behalf of BLLN investors.
BLLN shareholders who lost money in the November 18 decline can request a review of their losses or call (212) 363-7500.
Levi & Korsinsky, LLP -- Top 50 securities litigation firm (ISS, seven consecutive years). Over 70 professionals. Billions recovered.
Frequently Asked Questions About the BLLN Investigation
Q: How much did BLLN stock drop? A: Shares fell roughly 6% in premarket trading, and were falling 6% again by midday on November 18, 2026. The decline followed a report from short-seller Fuzzy Panda Research alleging improper billing practices, undisclosed regulatory scrutiny, weaknesses in clinical claims, and potential reimbursement and compliance problems at BillionToOne. Investors who purchased shares at allegedly inflated prices and suffered losses may be eligible to seek compensation.
Q: Which statements are being investigated as potentially misleading? A: The investigation concerns whether BillionToOne made materially false or misleading statements regarding its billing and reimbursement practices, as well as whether and in what detail it ought to have disclosed the alleged investigation and findings by the Tennessee regulatory bodies. When a short-seller report raising these issues was published on November 18, 2026, the stock price declined sharply.
Q: When did BillionToOne allegedly mislead investors? A: The investigation concerns statements made before the November 18, 2026 short-seller report that allegedly caused investors to purchase securities at inflated prices.
Q: What is a lead plaintiff and why does it matter? A: If the investigation proceeds to legal action, a lead plaintiff is the investor the court appoints to represent the group of affected investors. Lead plaintiffs are typically investors with the largest documented losses. Contacting the firm during the investigation phase preserves that option.
Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.
Q: What if I already sold my BLLN shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought BLLN and sold at a loss may still participate in the investigation.
Q: What if my BLLN losses are small -- is it still worth contacting a lawyer? A: Yes. There is no minimum loss amount required to participate in the investigation.
Q: What does it cost me to participate? A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys ' fees and expenses subject to court approval.
Attorney Advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
SOURCE:Levi & Korsinsky, LLP
View the original press release on ACCESS Newswire
© 2026 ACCESS Newswire. All Rights Reserved.












